Skip to content

Long-term Cardiovascular Risk in Cured Cushing's Patients

Role of Adipokines in Long-term Cardiovascular Risk in Cured Cushing's Patients

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00881283
Enrollment
1
Registered
2009-04-15
Start date
2008-09-08
Completion date
2010-03-30
Last updated
2020-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cushing's Disease

Keywords

Cushing's disease

Brief summary

The purpose of this study is to determine whether subjects who have been affected by Cushing's disease in the past maintain some different characteristics compared with subjects who have never been diagnosed with the disease.

Interventions

None listed

Sponsors

Massachusetts General Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
35 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* patients who have been cured of Cushing's disease at least 5 years ago.

Exclusion criteria

* patients who have been cured of Cushing's disease more than 15 years ago.

Design outcomes

Primary

MeasureTime frame
adipokine measurementsbaseline

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026